Nutriband (NTRB)

• Market cap: $85.9M
• 1 day: 3.17%
• 5 days: 12.42%
• 1 month: 5.15%
• 3 months: -5.92%
• 6 months: 12.42%
• Year to date: 57.14%
• 1 year: 63.62%
• 5 years: 24.78%
• 10 years: 24.78%
• Sector: Healthcare
• Industry: Biotechnology

About: Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.

Employees: 3

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

133% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 3

67% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 3

33% more capital invested

Capital invested by funds: $2.06M [Q1] → $2.73M (+$673K) [Q2]

25% more funds holding

Funds holding: 16 [Q1] → 20 (+4) [Q2]

0.1% more ownership

Funds ownership: 3.02% [Q1] → 3.12% (+0.1%) [Q2]